Enrolling by invitationNCT05942859
Applying Artificial Intelligence to the 12 Lead ECG for the Diagnosis of Pulmonary Hypertension: an Observational Study
Studying Pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Royal United Hospitals Bath NHS Foundation Trust
- Principal Investigator
- Dan Augustine, BSc, MBBS, MRCPRoyal United Bath NHS Foundation Trust
- Intervention
- Artificial Intelligence and Machine Learning technology(diagnostic_test)
- Enrollment
- 600 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Royal United Hospital Bath NHS Trust, Bath, United Kingdom
Collaborators
Liverpool John Moores University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05942859 on ClinicalTrials.govOther trials for Pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07593027A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
- RECRUITINGNANCT07563322Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary HypertensionVanderbilt University Medical Center
- ACTIVE NOT RECRUITINGNANCT07391228Cognitive Alterations in Pulmonary Arterial Hypertension (PAH)Alessandra Gorini
- RECRUITINGNANCT06871293Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19Fundación Cardioinfantil Instituto de Cardiología
- RECRUITINGNANCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary HypertensionTempus AI
- ACTIVE NOT RECRUITINGPHASE3NCT06274801Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)GB002, Inc.
- RECRUITINGPHASE2NCT05937854Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PHVA Office of Research and Development
- RECRUITINGNCT06291389Intraoperative Peak Airway Pressure Changes on Postoperative Pulmonary Function After Muscle PlicationAl-Azhar University